| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, CD1 | 99 | 2023 | 437 | 19.060 |
Why?
|
| Antigen Presentation | 61 | 2023 | 1284 | 6.670 |
Why?
|
| Mycobacterium tuberculosis | 57 | 2024 | 1825 | 5.870 |
Why?
|
| Lipids | 55 | 2023 | 3302 | 5.590 |
Why?
|
| T-Lymphocytes | 77 | 2023 | 10163 | 4.820 |
Why?
|
| Glycolipids | 35 | 2024 | 205 | 4.390 |
Why?
|
| Mycobacterium | 20 | 2023 | 249 | 3.680 |
Why?
|
| Receptors, Antigen, T-Cell | 29 | 2023 | 2524 | 3.130 |
Why?
|
| Antigens, Bacterial | 28 | 2021 | 1170 | 2.980 |
Why?
|
| T-Lymphocyte Subsets | 22 | 2021 | 1837 | 2.610 |
Why?
|
| Oxazoles | 13 | 2017 | 189 | 2.560 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 16 | 2019 | 804 | 2.460 |
Why?
|
| Lymphocyte Activation | 43 | 2021 | 5519 | 2.110 |
Why?
|
| Tuberculosis | 22 | 2023 | 1904 | 1.910 |
Why?
|
| Mycolic Acids | 10 | 2020 | 54 | 1.780 |
Why?
|
| Membrane Lipids | 6 | 2021 | 248 | 1.620 |
Why?
|
| Natural Killer T-Cells | 12 | 2021 | 315 | 1.580 |
Why?
|
| Glycoproteins | 11 | 2021 | 2260 | 1.500 |
Why?
|
| Antigens | 11 | 2023 | 1462 | 1.460 |
Why?
|
| Lipopeptides | 5 | 2017 | 75 | 1.390 |
Why?
|
| Phospholipids | 10 | 2022 | 781 | 1.380 |
Why?
|
| Antigens, CD1d | 9 | 2021 | 220 | 1.260 |
Why?
|
| Bacterial Proteins | 17 | 2020 | 3843 | 1.030 |
Why?
|
| Mycobacterium Infections | 5 | 2016 | 119 | 1.020 |
Why?
|
| Histocompatibility Antigens Class I | 9 | 2022 | 1366 | 1.000 |
Why?
|
| Autoantigens | 9 | 2022 | 891 | 0.990 |
Why?
|
| Dermatitis, Contact | 1 | 2023 | 129 | 0.890 |
Why?
|
| Skin | 10 | 2023 | 4353 | 0.870 |
Why?
|
| Trehalose | 5 | 2021 | 88 | 0.830 |
Why?
|
| Endosomes | 10 | 2015 | 520 | 0.820 |
Why?
|
| Terpenes | 3 | 2023 | 98 | 0.790 |
Why?
|
| Protein Conformation | 12 | 2019 | 4013 | 0.780 |
Why?
|
| Amino Acid Motifs | 4 | 2023 | 936 | 0.780 |
Why?
|
| T-Cell Antigen Receptor Specificity | 3 | 2017 | 87 | 0.750 |
Why?
|
| Galactosylceramides | 3 | 2017 | 92 | 0.750 |
Why?
|
| Lipid Metabolism | 14 | 2017 | 1887 | 0.740 |
Why?
|
| Lysosomes | 8 | 2023 | 893 | 0.710 |
Why?
|
| Nucleosides | 2 | 2023 | 138 | 0.710 |
Why?
|
| Autoimmunity | 4 | 2018 | 1348 | 0.690 |
Why?
|
| Antacids | 1 | 2019 | 99 | 0.680 |
Why?
|
| Antigen-Presenting Cells | 10 | 2021 | 969 | 0.670 |
Why?
|
| Dendritic Cells | 12 | 2015 | 2723 | 0.670 |
Why?
|
| Tissue Donors | 3 | 2019 | 2205 | 0.650 |
Why?
|
| Phagosomes | 1 | 2019 | 193 | 0.640 |
Why?
|
| Lipoproteins | 7 | 2016 | 876 | 0.630 |
Why?
|
| Diglycerides | 3 | 2019 | 176 | 0.600 |
Why?
|
| Models, Molecular | 14 | 2020 | 5454 | 0.600 |
Why?
|
| Siderophores | 4 | 2022 | 56 | 0.590 |
Why?
|
| Cell Wall | 4 | 2017 | 422 | 0.580 |
Why?
|
| K562 Cells | 7 | 2021 | 632 | 0.580 |
Why?
|
| Virulence Factors | 3 | 2024 | 509 | 0.540 |
Why?
|
| Molecular Structure | 7 | 2020 | 1907 | 0.520 |
Why?
|
| Mass Spectrometry | 12 | 2020 | 2203 | 0.510 |
Why?
|
| Antitubercular Agents | 3 | 2020 | 1319 | 0.500 |
Why?
|
| Skin Diseases | 1 | 2023 | 1065 | 0.500 |
Why?
|
| Lectins, C-Type | 4 | 2021 | 588 | 0.490 |
Why?
|
| Protein Multimerization | 5 | 2021 | 971 | 0.490 |
Why?
|
| Borrelia burgdorferi | 2 | 2019 | 180 | 0.490 |
Why?
|
| Rifampin | 1 | 2016 | 315 | 0.480 |
Why?
|
| Protein Binding | 16 | 2020 | 9387 | 0.480 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2014 | 89 | 0.470 |
Why?
|
| Arylsulfonates | 2 | 2021 | 8 | 0.460 |
Why?
|
| HEK293 Cells | 7 | 2021 | 4200 | 0.460 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 5 | 2017 | 276 | 0.450 |
Why?
|
| Stereoisomerism | 9 | 2020 | 625 | 0.450 |
Why?
|
| Chromatography, High Pressure Liquid | 7 | 2016 | 1574 | 0.450 |
Why?
|
| Drug Resistance, Microbial | 1 | 2016 | 860 | 0.440 |
Why?
|
| Cell Line | 23 | 2021 | 15994 | 0.440 |
Why?
|
| Iron | 5 | 2022 | 1773 | 0.430 |
Why?
|
| Actinomycetales | 1 | 2012 | 31 | 0.430 |
Why?
|
| Benzofurans | 2 | 2021 | 140 | 0.430 |
Why?
|
| Carbohydrates | 2 | 2007 | 391 | 0.420 |
Why?
|
| Cord Factors | 2 | 2020 | 6 | 0.420 |
Why?
|
| Humans | 133 | 2023 | 742088 | 0.400 |
Why?
|
| Animals | 62 | 2024 | 168561 | 0.390 |
Why?
|
| Biosynthetic Pathways | 1 | 2012 | 137 | 0.390 |
Why?
|
| Ligands | 11 | 2022 | 3293 | 0.380 |
Why?
|
| Mycobacterium kansasii | 2 | 2020 | 11 | 0.370 |
Why?
|
| Ceramides | 1 | 2011 | 198 | 0.370 |
Why?
|
| Lyme Disease | 2 | 2019 | 618 | 0.360 |
Why?
|
| Models, Immunological | 5 | 2019 | 527 | 0.350 |
Why?
|
| Molecular Sequence Data | 15 | 2014 | 18112 | 0.350 |
Why?
|
| Histocompatibility Antigens Class II | 5 | 2019 | 1470 | 0.340 |
Why?
|
| Toll-Like Receptors | 3 | 2009 | 592 | 0.340 |
Why?
|
| Minor Histocompatibility Antigens | 4 | 2022 | 298 | 0.320 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2021 | 810 | 0.310 |
Why?
|
| Salmonella typhi | 2 | 2019 | 200 | 0.300 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2022 | 341 | 0.300 |
Why?
|
| Structure-Activity Relationship | 7 | 2019 | 3133 | 0.290 |
Why?
|
| Mice | 33 | 2022 | 81045 | 0.290 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 2020 | 2552 | 0.290 |
Why?
|
| Mycobacterium marinum | 2 | 2024 | 26 | 0.280 |
Why?
|
| COP-Coated Vesicles | 2 | 2019 | 41 | 0.270 |
Why?
|
| Clone Cells | 5 | 2017 | 1692 | 0.270 |
Why?
|
| Gene Expression Regulation, Bacterial | 5 | 2020 | 1119 | 0.270 |
Why?
|
| Bee Venoms | 2 | 2015 | 14 | 0.270 |
Why?
|
| Macrophages | 6 | 2023 | 5655 | 0.270 |
Why?
|
| Crystallography, X-Ray | 7 | 2021 | 2014 | 0.260 |
Why?
|
| Viruses | 1 | 2009 | 374 | 0.260 |
Why?
|
| Amino Acid Sequence | 10 | 2014 | 13814 | 0.260 |
Why?
|
| Interleukin-1beta | 1 | 2011 | 972 | 0.260 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2010 | 986 | 0.250 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2005 | 101 | 0.250 |
Why?
|
| Metabolomics | 1 | 2012 | 1467 | 0.230 |
Why?
|
| Phosphatidylinositols | 3 | 2022 | 291 | 0.230 |
Why?
|
| Dibucaine | 1 | 2023 | 7 | 0.230 |
Why?
|
| Macrolides | 1 | 2004 | 201 | 0.230 |
Why?
|
| Superantigens | 1 | 2023 | 129 | 0.230 |
Why?
|
| Monocytes | 4 | 2020 | 2593 | 0.230 |
Why?
|
| Graves Disease | 1 | 2005 | 241 | 0.230 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2023 | 75 | 0.220 |
Why?
|
| Virus Diseases | 1 | 2009 | 710 | 0.220 |
Why?
|
| Databases, Factual | 3 | 2012 | 7716 | 0.220 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2015 | 4438 | 0.220 |
Why?
|
| Membrane Proteins | 4 | 2020 | 7873 | 0.220 |
Why?
|
| Toll-Like Receptor 2 | 3 | 2011 | 354 | 0.220 |
Why?
|
| Latent Tuberculosis | 2 | 2016 | 225 | 0.220 |
Why?
|
| Cross Reactions | 4 | 2019 | 841 | 0.220 |
Why?
|
| Flow Cytometry | 8 | 2016 | 5975 | 0.210 |
Why?
|
| Mycobacterium bovis | 3 | 2016 | 150 | 0.210 |
Why?
|
| Membrane Transport Proteins | 2 | 2020 | 1028 | 0.210 |
Why?
|
| Embolism, Fat | 1 | 2002 | 47 | 0.210 |
Why?
|
| Recombinant Proteins | 8 | 2017 | 6608 | 0.210 |
Why?
|
| Polyisoprenyl Phosphate Sugars | 1 | 2001 | 2 | 0.210 |
Why?
|
| Signal Transduction | 4 | 2018 | 23387 | 0.200 |
Why?
|
| Tuberculosis Vaccines | 2 | 2019 | 49 | 0.200 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2001 | 318 | 0.190 |
Why?
|
| Fatty Acids | 6 | 2023 | 1806 | 0.190 |
Why?
|
| Phosphatidylglycerols | 2 | 2022 | 34 | 0.190 |
Why?
|
| Base Sequence | 8 | 2014 | 12797 | 0.190 |
Why?
|
| Cell Membrane | 6 | 2021 | 3744 | 0.190 |
Why?
|
| Models, Biological | 8 | 2014 | 9581 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 4751 | 0.190 |
Why?
|
| Transfection | 5 | 2015 | 5892 | 0.190 |
Why?
|
| Bacterial Infections | 1 | 2009 | 1389 | 0.190 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2020 | 32 | 0.190 |
Why?
|
| Immunophenotyping | 3 | 2020 | 1866 | 0.190 |
Why?
|
| Balsams | 1 | 2020 | 6 | 0.190 |
Why?
|
| Intracranial Embolism | 1 | 2002 | 202 | 0.180 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2000 | 36 | 0.180 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 3847 | 0.180 |
Why?
|
| Biological Transport | 5 | 2015 | 2119 | 0.180 |
Why?
|
| Antigens, Plant | 1 | 2020 | 86 | 0.180 |
Why?
|
| Phosphatidic Acids | 1 | 2019 | 49 | 0.180 |
Why?
|
| Binding Sites | 3 | 2019 | 6115 | 0.170 |
Why?
|
| Virulence | 4 | 2022 | 1328 | 0.170 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2002 | 475 | 0.170 |
Why?
|
| Endocytosis | 5 | 2014 | 983 | 0.170 |
Why?
|
| Glycosylation | 5 | 2014 | 1123 | 0.160 |
Why?
|
| Group IV Phospholipases A2 | 2 | 2016 | 60 | 0.160 |
Why?
|
| Mycobacterium leprae | 2 | 2017 | 97 | 0.160 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2013 | 407 | 0.160 |
Why?
|
| Bacteria | 1 | 2009 | 2102 | 0.160 |
Why?
|
| Dermatitis, Atopic | 2 | 2022 | 653 | 0.160 |
Why?
|
| Peptides | 3 | 2019 | 4392 | 0.150 |
Why?
|
| Conserved Sequence | 3 | 2019 | 1202 | 0.150 |
Why?
|
| Immunologic Techniques | 1 | 2017 | 218 | 0.150 |
Why?
|
| Leprosy | 1 | 2017 | 127 | 0.150 |
Why?
|
| Hordeum | 1 | 2016 | 20 | 0.150 |
Why?
|
| Sphingolipids | 1 | 2018 | 159 | 0.150 |
Why?
|
| Coat Protein Complex I | 2 | 2019 | 32 | 0.140 |
Why?
|
| Receptors, Immunologic | 2 | 2020 | 1423 | 0.140 |
Why?
|
| Genome, Plant | 1 | 2016 | 77 | 0.140 |
Why?
|
| Interleukin-2 | 4 | 2015 | 1887 | 0.140 |
Why?
|
| Polyketide Synthases | 2 | 2017 | 28 | 0.140 |
Why?
|
| Langerhans Cells | 2 | 2022 | 173 | 0.140 |
Why?
|
| Immunologic Memory | 2 | 2021 | 1348 | 0.140 |
Why?
|
| Killer Cells, Natural | 6 | 2012 | 2133 | 0.140 |
Why?
|
| Quantitative Trait Loci | 2 | 2022 | 2015 | 0.140 |
Why?
|
| Chromatography, Liquid | 3 | 2020 | 977 | 0.140 |
Why?
|
| Wasp Venoms | 1 | 2015 | 18 | 0.140 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2867 | 0.130 |
Why?
|
| Pyroglyphidae | 1 | 2016 | 87 | 0.130 |
Why?
|
| Receptors, IgG | 2 | 2009 | 582 | 0.130 |
Why?
|
| Histocompatibility Antigens | 2 | 2015 | 471 | 0.130 |
Why?
|
| Isomerism | 1 | 2015 | 201 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 5 | 2016 | 4801 | 0.130 |
Why?
|
| Dermatitis | 1 | 2017 | 197 | 0.130 |
Why?
|
| Lactones | 1 | 2017 | 329 | 0.130 |
Why?
|
| Membrane Microdomains | 1 | 2016 | 202 | 0.130 |
Why?
|
| Allergens | 2 | 2020 | 1314 | 0.130 |
Why?
|
| Gene Expression Regulation | 6 | 2022 | 12071 | 0.130 |
Why?
|
| Intermediate Filament Proteins | 1 | 2016 | 269 | 0.130 |
Why?
|
| Acyltransferases | 3 | 2017 | 294 | 0.130 |
Why?
|
| Decidua | 1 | 2015 | 86 | 0.130 |
Why?
|
| Enzyme-Linked Immunospot Assay | 2 | 2015 | 130 | 0.130 |
Why?
|
| Cell Separation | 4 | 2016 | 1749 | 0.130 |
Why?
|
| Immunity | 2 | 2012 | 1011 | 0.120 |
Why?
|
| Hand Strength | 1 | 2017 | 444 | 0.120 |
Why?
|
| Th17 Cells | 1 | 2021 | 765 | 0.120 |
Why?
|
| Protein Isoforms | 5 | 2014 | 1727 | 0.120 |
Why?
|
| Carbohydrate Conformation | 2 | 2007 | 208 | 0.120 |
Why?
|
| Chromatography, Thin Layer | 2 | 2012 | 223 | 0.120 |
Why?
|
| Milk | 1 | 2017 | 449 | 0.120 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 3769 | 0.120 |
Why?
|
| Immunotherapy, Active | 1 | 1994 | 60 | 0.120 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 2183 | 0.120 |
Why?
|
| Biological Assay | 1 | 2017 | 652 | 0.120 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2014 | 305 | 0.120 |
Why?
|
| Peru | 3 | 2022 | 881 | 0.120 |
Why?
|
| Epitopes | 3 | 2015 | 2569 | 0.120 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2017 | 1871 | 0.120 |
Why?
|
| Models, Chemical | 2 | 2009 | 626 | 0.120 |
Why?
|
| AIDS-Related Complex | 1 | 1993 | 111 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2012 | 713 | 0.110 |
Why?
|
| Genome | 1 | 2021 | 1803 | 0.110 |
Why?
|
| Prevalence | 2 | 2020 | 15194 | 0.110 |
Why?
|
| Staphylococcus | 2 | 2023 | 155 | 0.110 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 293 | 0.110 |
Why?
|
| Interferon-gamma | 7 | 2021 | 3199 | 0.110 |
Why?
|
| Propaganda | 1 | 1992 | 5 | 0.110 |
Why?
|
| Protein Transport | 2 | 2013 | 1988 | 0.110 |
Why?
|
| Psoriasis | 2 | 2017 | 898 | 0.110 |
Why?
|
| Mental Healing | 1 | 1992 | 29 | 0.100 |
Why?
|
| Dimerization | 1 | 2014 | 893 | 0.100 |
Why?
|
| Jurkat Cells | 3 | 2021 | 742 | 0.100 |
Why?
|
| 5' Untranslated Regions | 1 | 2013 | 249 | 0.100 |
Why?
|
| Books | 1 | 1992 | 23 | 0.100 |
Why?
|
| Cattle | 3 | 2013 | 3923 | 0.100 |
Why?
|
| Hyperlipidemias | 1 | 2017 | 786 | 0.100 |
Why?
|
| Saposins | 1 | 2012 | 27 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1477 | 0.100 |
Why?
|
| Lectins | 1 | 2014 | 514 | 0.100 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2009 | 361 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2013 | 782 | 0.100 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2002 | 1461 | 0.100 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2012 | 507 | 0.100 |
Why?
|
| Pneumonia | 1 | 2023 | 2117 | 0.100 |
Why?
|
| Guinea Pigs | 1 | 2013 | 1386 | 0.100 |
Why?
|
| Food Hypersensitivity | 1 | 2018 | 622 | 0.100 |
Why?
|
| Erythema Chronicum Migrans | 1 | 2011 | 47 | 0.100 |
Why?
|
| Software | 3 | 2021 | 4434 | 0.090 |
Why?
|
| Lysine | 2 | 2020 | 1008 | 0.090 |
Why?
|
| Lung | 6 | 2023 | 9826 | 0.090 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2020 | 1884 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2015 | 3760 | 0.090 |
Why?
|
| Tuberculosis, Bovine | 1 | 2009 | 9 | 0.090 |
Why?
|
| Lipopolysaccharides | 4 | 2013 | 2211 | 0.090 |
Why?
|
| Paratuberculosis | 1 | 2009 | 4 | 0.090 |
Why?
|
| Protein Structure, Quaternary | 1 | 2011 | 437 | 0.090 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2012 | 962 | 0.090 |
Why?
|
| Glycerophospholipids | 1 | 2009 | 32 | 0.090 |
Why?
|
| Organ Specificity | 1 | 2015 | 2003 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2022 | 4379 | 0.090 |
Why?
|
| Hydroxy Acids | 1 | 2009 | 18 | 0.090 |
Why?
|
| Coculture Techniques | 4 | 2017 | 1341 | 0.090 |
Why?
|
| Antibody Specificity | 1 | 2011 | 1094 | 0.090 |
Why?
|
| Methylation | 1 | 2012 | 1107 | 0.090 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2020 | 2749 | 0.080 |
Why?
|
| DNA Primers | 2 | 2012 | 2892 | 0.080 |
Why?
|
| Escherichia coli | 4 | 2019 | 4214 | 0.080 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 18006 | 0.080 |
Why?
|
| Hepatitis B virus | 1 | 2012 | 513 | 0.080 |
Why?
|
| Butyrates | 1 | 2009 | 163 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 3862 | 0.080 |
Why?
|
| Species Specificity | 1 | 2013 | 2479 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2009 | 1820 | 0.080 |
Why?
|
| Hepatitis B, Chronic | 1 | 2012 | 393 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2010 | 675 | 0.080 |
Why?
|
| Amino Acids | 2 | 2014 | 1727 | 0.080 |
Why?
|
| CHO Cells | 2 | 2012 | 1407 | 0.070 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 902 | 0.070 |
Why?
|
| Cells, Cultured | 8 | 2017 | 19223 | 0.070 |
Why?
|
| Biofilms | 1 | 2011 | 613 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 3 | 2002 | 6313 | 0.070 |
Why?
|
| Diazepam Binding Inhibitor | 1 | 2006 | 4 | 0.070 |
Why?
|
| Hydrogen Bonding | 2 | 2005 | 293 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 15494 | 0.070 |
Why?
|
| Evolution, Molecular | 2 | 2020 | 1937 | 0.070 |
Why?
|
| Hypersensitivity | 1 | 2015 | 1093 | 0.070 |
Why?
|
| Peptide Synthases | 1 | 2006 | 80 | 0.070 |
Why?
|
| Cricetinae | 2 | 2012 | 2471 | 0.070 |
Why?
|
| Disease Progression | 2 | 2021 | 13256 | 0.070 |
Why?
|
| Mutant Proteins | 1 | 2008 | 500 | 0.070 |
Why?
|
| Monosaccharides | 1 | 2006 | 70 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 6382 | 0.070 |
Why?
|
| Cell-Free System | 1 | 2006 | 344 | 0.070 |
Why?
|
| Interleukins | 1 | 2010 | 791 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2021 | 21719 | 0.070 |
Why?
|
| Galactans | 1 | 2005 | 31 | 0.070 |
Why?
|
| Mannose | 1 | 2006 | 124 | 0.070 |
Why?
|
| Adjuvants, Immunologic | 2 | 2012 | 1000 | 0.070 |
Why?
|
| Sigma Factor | 1 | 2006 | 174 | 0.070 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2019 | 880 | 0.060 |
Why?
|
| Acylation | 2 | 2018 | 107 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 1707 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2011 | 4211 | 0.060 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1993 | 1255 | 0.060 |
Why?
|
| Golgi Apparatus | 2 | 2019 | 410 | 0.060 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1993 | 2231 | 0.060 |
Why?
|
| Hydroxylation | 1 | 2004 | 141 | 0.060 |
Why?
|
| Adult | 14 | 2022 | 213712 | 0.060 |
Why?
|
| Genetic Complementation Test | 1 | 2004 | 561 | 0.060 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2005 | 246 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2009 | 1835 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2022 | 17400 | 0.060 |
Why?
|
| Peptidoglycan | 1 | 2005 | 246 | 0.060 |
Why?
|
| Stearic Acids | 1 | 2023 | 53 | 0.060 |
Why?
|
| Oleic Acid | 1 | 2023 | 85 | 0.060 |
Why?
|
| Hair | 1 | 2006 | 483 | 0.060 |
Why?
|
| Cell Line, Transformed | 2 | 2021 | 898 | 0.060 |
Why?
|
| Immunity, Cellular | 1 | 2009 | 1606 | 0.060 |
Why?
|
| RNA | 1 | 2013 | 2747 | 0.060 |
Why?
|
| Major Histocompatibility Complex | 1 | 2006 | 935 | 0.050 |
Why?
|
| Phylogeny | 2 | 2019 | 2797 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 2217 | 0.050 |
Why?
|
| BCG Vaccine | 2 | 2022 | 367 | 0.050 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2002 | 53 | 0.050 |
Why?
|
| Hybridomas | 1 | 2003 | 452 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 3 | 2011 | 9274 | 0.050 |
Why?
|
| Capsaicin | 1 | 2003 | 229 | 0.050 |
Why?
|
| Phosphatidylethanolamines | 2 | 2017 | 134 | 0.050 |
Why?
|
| Enterotoxins | 1 | 2023 | 368 | 0.050 |
Why?
|
| Blood Buffy Coat | 1 | 2021 | 11 | 0.050 |
Why?
|
| Biotin | 1 | 2023 | 253 | 0.050 |
Why?
|
| HeLa Cells | 3 | 2019 | 3127 | 0.050 |
Why?
|
| Hepatocytes | 2 | 2012 | 1209 | 0.050 |
Why?
|
| Binding, Competitive | 2 | 2019 | 1159 | 0.050 |
Why?
|
| Carbohydrate Sequence | 1 | 2001 | 414 | 0.050 |
Why?
|
| Armadillos | 1 | 2000 | 7 | 0.050 |
Why?
|
| Lysophospholipids | 2 | 2015 | 331 | 0.050 |
Why?
|
| Self Tolerance | 1 | 2001 | 124 | 0.050 |
Why?
|
| Gene Expression | 4 | 2019 | 7790 | 0.050 |
Why?
|
| Male | 15 | 2021 | 349538 | 0.050 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2003 | 315 | 0.050 |
Why?
|
| Female | 15 | 2021 | 379592 | 0.050 |
Why?
|
| Dolichol Monophosphate Mannose | 1 | 2000 | 2 | 0.050 |
Why?
|
| Adenosine | 2 | 2016 | 823 | 0.050 |
Why?
|
| Mycobacterium avium | 1 | 2000 | 28 | 0.050 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2003 | 419 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2019 | 3585 | 0.050 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2000 | 94 | 0.050 |
Why?
|
| Methyltransferases | 1 | 2023 | 367 | 0.050 |
Why?
|
| Patch Tests | 1 | 2020 | 53 | 0.040 |
Why?
|
| Skin Care | 1 | 2020 | 49 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2022 | 407 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2005 | 1438 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 4664 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2021 | 2713 | 0.040 |
Why?
|
| Liposomes | 2 | 2014 | 758 | 0.040 |
Why?
|
| Zebrafish | 2 | 2024 | 2990 | 0.040 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2019 | 34 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2006 | 1051 | 0.040 |
Why?
|
| Cytokines | 4 | 2016 | 7317 | 0.040 |
Why?
|
| Esters | 1 | 2020 | 210 | 0.040 |
Why?
|
| Diet | 1 | 2017 | 7923 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 23320 | 0.040 |
Why?
|
| Bronchi | 1 | 2003 | 840 | 0.040 |
Why?
|
| Cosmetics | 1 | 2020 | 97 | 0.040 |
Why?
|
| Middle Aged | 8 | 2021 | 213127 | 0.040 |
Why?
|
| Culture Media | 1 | 2020 | 902 | 0.040 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2020 | 104 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2020 | 228 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2022 | 670 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2005 | 1172 | 0.040 |
Why?
|
| South Africa | 2 | 2015 | 1728 | 0.040 |
Why?
|
| Kinetics | 2 | 2020 | 6474 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 2126 | 0.040 |
Why?
|
| Mycobacterium phlei | 1 | 2016 | 2 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 9410 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2008 | 4024 | 0.040 |
Why?
|
| beta 2-Microglobulin | 1 | 1998 | 315 | 0.040 |
Why?
|
| Typhoid Fever | 1 | 2019 | 196 | 0.040 |
Why?
|
| Bacteroides fragilis | 1 | 2018 | 212 | 0.040 |
Why?
|
| Rhodococcus equi | 1 | 2016 | 16 | 0.040 |
Why?
|
| DNA, Plant | 1 | 2016 | 50 | 0.040 |
Why?
|
| HIV Infections | 2 | 2015 | 16678 | 0.040 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 494 | 0.040 |
Why?
|
| Biological Transport, Active | 2 | 2011 | 349 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2004 | 2751 | 0.040 |
Why?
|
| Haploidy | 1 | 2016 | 136 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2015 | 1157 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 1994 | 6347 | 0.030 |
Why?
|
| Plant Extracts | 1 | 2020 | 469 | 0.030 |
Why?
|
| Plant Leaves | 1 | 2016 | 143 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 4554 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 2017 | 411 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2017 | 590 | 0.030 |
Why?
|
| Larva | 1 | 2017 | 517 | 0.030 |
Why?
|
| Diterpenes | 1 | 2016 | 173 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2016 | 279 | 0.030 |
Why?
|
| Insect Bites and Stings | 1 | 2015 | 67 | 0.030 |
Why?
|
| Protein Footprinting | 1 | 2014 | 10 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 16665 | 0.030 |
Why?
|
| Phenotype | 3 | 2021 | 16331 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2013 | 1723 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2016 | 594 | 0.030 |
Why?
|
| Phospholipases A2 | 1 | 2015 | 202 | 0.030 |
Why?
|
| Demyelinating Diseases | 1 | 2017 | 363 | 0.030 |
Why?
|
| Toxoplasma | 1 | 1996 | 150 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 390 | 0.030 |
Why?
|
| Bacterial Typing Techniques | 1 | 2015 | 256 | 0.030 |
Why?
|
| Genome, Bacterial | 2 | 2009 | 754 | 0.030 |
Why?
|
| Computational Biology | 2 | 2021 | 3518 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2019 | 1179 | 0.030 |
Why?
|
| Salts | 1 | 2014 | 65 | 0.030 |
Why?
|
| CD40 Ligand | 1 | 2015 | 526 | 0.030 |
Why?
|
| Phytohemagglutinins | 1 | 1993 | 170 | 0.030 |
Why?
|
| Myelin Sheath | 1 | 2017 | 652 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 72145 | 0.030 |
Why?
|
| Receptors, CCR5 | 1 | 2015 | 497 | 0.030 |
Why?
|
| Leukapheresis | 1 | 1993 | 131 | 0.030 |
Why?
|
| Sputum | 1 | 2015 | 474 | 0.030 |
Why?
|
| HIV-1 | 1 | 2010 | 6934 | 0.030 |
Why?
|
| Feces | 1 | 2019 | 1394 | 0.030 |
Why?
|
| Rats, Inbred Strains | 1 | 1994 | 2191 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2014 | 212 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 913 | 0.030 |
Why?
|
| Phospholipases A2, Secretory | 1 | 2012 | 31 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 1866 | 0.030 |
Why?
|
| Immunity, Innate | 2 | 2022 | 2956 | 0.030 |
Why?
|
| History, 15th Century | 1 | 1992 | 31 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2012 | 212 | 0.030 |
Why?
|
| Printing | 1 | 1992 | 46 | 0.030 |
Why?
|
| History, 16th Century | 1 | 1992 | 72 | 0.030 |
Why?
|
| Neuroglia | 1 | 2017 | 925 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1996 | 1368 | 0.030 |
Why?
|
| Immunodominant Epitopes | 1 | 2012 | 267 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 552 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 2024 | 0.020 |
Why?
|
| Acute Disease | 1 | 2002 | 7141 | 0.020 |
Why?
|
| Mutation | 5 | 2019 | 29717 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2014 | 1245 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 1994 | 11039 | 0.020 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2012 | 305 | 0.020 |
Why?
|
| Genotype | 2 | 2019 | 12946 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2016 | 2422 | 0.020 |
Why?
|
| Desensitization, Immunologic | 1 | 2015 | 483 | 0.020 |
Why?
|
| Intracellular Fluid | 2 | 2000 | 203 | 0.020 |
Why?
|
| Molecular Typing | 1 | 2010 | 106 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 892 | 0.020 |
Why?
|
| Mycobacterium avium subsp. paratuberculosis | 1 | 2009 | 4 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2016 | 2633 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 1994 | 2085 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 2014 | 1078 | 0.020 |
Why?
|
| Inflammation | 1 | 2009 | 10578 | 0.020 |
Why?
|
| Secretory Pathway | 1 | 2009 | 51 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2019 | 2572 | 0.020 |
Why?
|
| Lipid Bilayers | 1 | 2012 | 381 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3256 | 0.020 |
Why?
|
| Lymphocyte Subsets | 1 | 2010 | 315 | 0.020 |
Why?
|
| Germany | 1 | 1992 | 860 | 0.020 |
Why?
|
| Body Temperature | 1 | 2012 | 776 | 0.020 |
Why?
|
| Axons | 1 | 2017 | 1681 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2013 | 1547 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1993 | 1583 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 5867 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2014 | 1382 | 0.020 |
Why?
|
| Molecular Mimicry | 1 | 2009 | 201 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2017 | 2128 | 0.020 |
Why?
|
| Infant | 2 | 2022 | 35070 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2008 | 65 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 4742 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2012 | 1096 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2013 | 13029 | 0.020 |
Why?
|
| Glucose | 1 | 2020 | 4391 | 0.020 |
Why?
|
| Mice, Nude | 1 | 1994 | 3689 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 7770 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 712 | 0.020 |
Why?
|
| Sex Factors | 1 | 2021 | 10392 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2002 | 2837 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 21821 | 0.020 |
Why?
|
| Serum | 1 | 2008 | 212 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2018 | 8436 | 0.020 |
Why?
|
| Fatty Alcohols | 1 | 2006 | 23 | 0.020 |
Why?
|
| Down-Regulation | 1 | 1994 | 3001 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 1310 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 6171 | 0.020 |
Why?
|
| Algorithms | 2 | 2021 | 13853 | 0.020 |
Why?
|
| Antibodies | 1 | 2014 | 2459 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 2715 | 0.020 |
Why?
|
| HIV | 1 | 1993 | 1600 | 0.020 |
Why?
|
| Adolescent | 3 | 2021 | 85649 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2009 | 9735 | 0.020 |
Why?
|
| Sulfoglycosphingolipids | 1 | 2005 | 19 | 0.020 |
Why?
|
| Aldehydes | 1 | 2006 | 167 | 0.020 |
Why?
|
| Immunization | 1 | 2009 | 1255 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 7153 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2010 | 2557 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2009 | 1056 | 0.020 |
Why?
|
| Age Factors | 1 | 2021 | 18355 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 4414 | 0.010 |
Why?
|
| Crystallization | 1 | 2005 | 525 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 2002 | 4322 | 0.010 |
Why?
|
| Hydrogenation | 1 | 2003 | 21 | 0.010 |
Why?
|
| Methanol | 1 | 2003 | 85 | 0.010 |
Why?
|
| Aged | 3 | 2021 | 162944 | 0.010 |
Why?
|
| PPAR gamma | 1 | 2006 | 493 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 19862 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 7901 | 0.010 |
Why?
|
| Receptors, LDL | 1 | 2005 | 475 | 0.010 |
Why?
|
| Goats | 1 | 2003 | 172 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 2003 | 175 | 0.010 |
Why?
|
| Rats | 2 | 2003 | 24265 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2016 | 6191 | 0.010 |
Why?
|
| Nanoparticles | 1 | 2014 | 1902 | 0.010 |
Why?
|
| Tuberculin Test | 1 | 2003 | 214 | 0.010 |
Why?
|
| Young Adult | 2 | 2021 | 56350 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 24913 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2010 | 2899 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2017 | 14554 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 3504 | 0.010 |
Why?
|
| Oxygen | 1 | 2013 | 4169 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2005 | 1802 | 0.010 |
Why?
|
| Biological Products | 1 | 2009 | 856 | 0.010 |
Why?
|
| Glutathione | 1 | 2003 | 586 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2000 | 3770 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 1670 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 12220 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 39004 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2012 | 5019 | 0.010 |
Why?
|
| Alanine | 1 | 2001 | 572 | 0.010 |
Why?
|
| Anilino Naphthalenesulfonates | 1 | 1998 | 16 | 0.010 |
Why?
|
| Triglycerides | 1 | 2006 | 2450 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1998 | 319 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2013 | 6540 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3920 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2022 | 53187 | 0.010 |
Why?
|
| Genomics | 1 | 2013 | 5692 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1998 | 281 | 0.010 |
Why?
|
| Triazoles | 1 | 2003 | 907 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1998 | 402 | 0.010 |
Why?
|
| Temperature | 1 | 2003 | 2207 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 4886 | 0.010 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1996 | 97 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2001 | 1792 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 57683 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1996 | 329 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1998 | 689 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2010 | 9144 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 40955 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 7721 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2009 | 5100 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1998 | 1263 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1998 | 2505 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2013 | 12164 | 0.010 |
Why?
|
| Pregnancy | 1 | 2015 | 29087 | 0.010 |
Why?
|
| Child | 1 | 2021 | 77478 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 3800 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 10943 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2008 | 11470 | 0.010 |
Why?
|